Form 8-K - Current report:
SEC Accession No. 0000882104-20-000094
Filing Date
2020-06-29
Accepted
2020-06-29 20:15:11
Documents
142
Period of Report
2020-06-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a202006308-kdoc.htm 8-K 41801
2 EXHIBIT 23.1 a202006308-kex231.htm EX-23.1 2918
3 EXHIBIT 99.1 a202006308-kex991.htm EX-99.1 3008625
  Complete submission text file 0000882104-20-000094.txt   18758737

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT pdli-20200629.xml EX-101.INS 3946909
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pdli-20200629.xsd EX-101.SCH 130520
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pdli-20200629_cal.xml EX-101.CAL 172635
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pdli-20200629_def.xml EX-101.DEF 996474
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pdli-20200629_lab.xml EX-101.LAB 1624953
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pdli-20200629_pre.xml EX-101.PRE 1255402
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

EIN.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 20999471
SIC: 2836 Biological Products, (No Diagnostic Substances)